- IGG AIRBORNE KINGDOM SKIN
- IGG AIRBORNE KINGDOM PATCH
evaluating cross-reactivity between insect venoms or. IGG AIRBORNE KINGDOM SKIN
when clinical history suggests an unusually greater risk of anaphylaxis from skin testing. uncooperative patients (eg, small children, individuals with mental or physical impairments). presence of widespread skin disease (eg, dermatographism, ichthyosis, intensive dermatitis or generalized eczema). patients receiving skin test suppressive medication therapy that cannot be temporarily discontinued (eg, antihistamines or beta blockers). In Vitro IgE Antibody Tests (RAST, MAST, FAST, ELISA, ImmunoCAP) are considered medically necessary for Treatment with that drug class is essential. There is no effective alternative drug and. 
History of allergy to a particular drug and. 
Drugs when all of the following are met:.Food or other substances (i.e., metabisulfite) or.Bronchial challenge test is being used to identify new allergens for which skin or blood testing has not been validated or.
IGG AIRBORNE KINGDOM PATCH
Photo Patch Testingįor diagnosing photo-allergy (e.g., photo-allergic contact dermatitis).įor evaluating photo-sensitivity disorders.įor testing with methacholine, histamine or antigens in defining asthma or airway hyperactivity when either of the following conditions is met: Skin Patch Testingįor diagnosing contact allergic dermatitis (up to 80 units are considered medically necessary).Īetna considers skin patch testing experimental and investigational for irritable bowel syndrome because its clinical value for this indication has not been established. An additional 40 antigens or 80 IDT injections may be medically necessary if any of the initial test results is positive. It is inappropriate to use SET in place of skin testing however, when used to determine the starting dose for immunotherapy in highly allergic members, up to 14 titration tests may be necessary. Members highly allergic to hymenoptera venom allergy (stinging insects) or.(also known as intradermal dilutional testing (IDT)) for determining the starting dose for immunotherapy for: However, in most cases, fewer tests are required. The evaluation of inhalant allergy may require up to 70 percutaneous tests, followed by up to 40 intracutaneous tests (which are usually performed when percutaneous tests are negative). Number of epicutaneous (percutaneous) and intracutaneous (intradermal) skin tests: Hymenoptera venom allergy (stinging insects) or.
When IgE-mediated reactions occur to any of the following:
Specific drugs (penicillins and macromolecular agents). When immunoglobulin E (IgE)-mediated reactions occur to any of the following: Test technique and/or allergens tested must have proven efficacy demonstrated through scientifically valid medical studies published in the peer-reviewed literature.Īetna considers the following allergy tests medically necessary: Epicutaneous (scratch, prick or puncture. 
Testing must correlate specifically to the member's history, risk of exposure and physical findings and. Symptoms are not adequately controlled by empiric conservative therapy and. Based on a review of the medical literature and the position statements of scientific organizations in the field of allergy and immunology, Aetna considers the specific allergy testing and treatment described below medically necessary in accordance with the selection criteria noted.Īetna considers specific allergy testing medically necessary for members with clinically significant allergic history of symptoms when all of the following criteria are met: Aetna considers specific allergy testing and allergy immunotherapy medically necessary for members with clinically significant allergic symptoms.
0 kommentar(er)
